Understanding Your Prescription Weight Loss Options
Wegovy to Mounjaro Conversion Chart: Understanding Prescription Weight Loss Mechanisms
When comparing Wegovy to Mounjaro for prescription weight loss, it's essential to understand their different mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors as a dual agonist. This fundamental difference affects how each treatment influences appetite regulation and blood sugar control. Both are prescription-only medicines that require clinical assessment and must be used alongside lifestyle modifications for optimal results.
The conversion between these treatments isn't simply a matter of equivalent dosing, as they have different pharmacological profiles and dosing schedules. Wegovy follows a structured 20-week escalation protocol starting at 0.25mg weekly, whilst Mounjaro uses a different escalation pattern beginning at 2.5mg weekly. Your prescriber at EverydayMeds (GPhC #9012878) will evaluate your current treatment response, side effect profile, and individual circumstances when considering any transition between these prescription weight loss options.
Wegovy to Mounjaro Conversion Chart: Pricing and Value Comparison
Understanding the cost implications of your Wegovy to Mounjaro conversion choice is crucial for long-term treatment planning. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. New customers benefit from discount code FIRST40, whilst returning customers use DOSE25 at checkout. Our convenient bundle options include the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99, providing a complete initial escalation sequence.
When evaluating your Wegovy to Mounjaro conversion options, consider that both treatments represent significant investments in your health journey. Our Getting Started bundles offer practical advantages, such as the Progress Duo (0.5mg & 1mg) at £189.99, ensuring continuity of supply during dose transitions. The Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, eliminating the need for frequent reordering. Both treatments are available through our streamlined prescription service, with clinical assessment, prescriber review, and next-day cold-chain delivery included in every order.
Clinical Evidence for Wegovy to Mounjaro Conversion Decisions
The STEP clinical trial programme demonstrates Wegovy's efficacy in weight management, with patients achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The STEP 1 trial showed sustained weight loss over 68 weeks, whilst STEP 5 confirmed maintenance of approximately clinically studied weight loss at two years. These results were achieved alongside a reduced-calorie diet and increased physical activity in controlled clinical settings.
When considering a Wegovy to Mounjaro conversion, your prescriber will evaluate your individual response to current treatment and clinical circumstances. Both treatments have demonstrated cardiovascular benefits in their respective clinical programmes, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events. The decision between treatments should be based on your specific medical history, treatment response, and tolerability profile rather than direct comparison of trial results, as these studies involved different patient populations and methodologies.
How Wegovy Works in Your Prescription Weight Loss Journey
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines that signals satiety to your brain. This mechanism helps reduce appetite and promotes feelings of fullness after smaller meals, potentially making it easier to maintain a reduced-calorie diet. The medication also slows gastric emptying, contributing to prolonged satiety, and may influence food cravings by acting on appetite control centres in the brain. Understanding this mechanism is crucial when considering any Wegovy to Mounjaro conversion, as the dual-agonist approach of Mounjaro adds GIP receptor activation to this GLP-1 effect. Your response to Wegovy's single-pathway approach may inform whether the additional GIP component in Mounjaro could be beneficial for your specific weight management needs.
Ordering Process for Your Wegovy to Mounjaro Conversion Assessment
Beginning your Wegovy to Mounjaro conversion evaluation at EverydayMeds starts with our comprehensive 3-minute online clinical assessment, designed to capture your current treatment experience and medical history. Our prescribers review each assessment within 3 working days (or 24 hours with express service), evaluating your suitability for either treatment option based on MHRA licensing criteria and clinical guidelines. The assessment covers your current dose, treatment duration, response, and any side effects experienced with your current prescription weight loss medication. Once approved, your chosen treatment is dispatched via next-day cold-chain delivery, maintaining the precise temperature control required for these prescription-only medicines. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the prescribing and dispensing process, providing peace of mind for your weight management journey.
Storage and Practical Considerations for Wegovy to Mounjaro Transitions
Wegovy offers practical storage advantages that may influence your conversion decision, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature stability. Both treatments require initial refrigerated storage at 2-8°C and use pre-filled injection pens for weekly administration. Wegovy's FlexTouch pen system provides dose escalation from 0.25mg through to 2.4mg maintenance, with each pen containing four weekly doses except the starter 0.25mg pen which contains six doses. The mandatory dose escalation protocol cannot be skipped, requiring systematic progression through each dose level to minimise gastrointestinal side effects. When transitioning between treatments, your prescriber will provide specific guidance on timing, storage requirements, and any washout period that may be necessary for your individual circumstances.
Personalised Wegovy to Mounjaro Conversion Planning for Prescription Weight Loss
Your individual Wegovy to Mounjaro conversion strategy depends on multiple factors including current dose, treatment duration, efficacy, and tolerability profile. Patients who have reached Wegovy's maintenance 2.4mg dose with good tolerability but suboptimal weight loss response may be candidates for Mounjaro's dual-mechanism approach. Conversely, those experiencing gastrointestinal side effects on Wegovy might benefit from Mounjaro's different dosing schedule and pharmacological profile. The conversion timing is crucial, as both treatments require careful dose escalation to maintain tolerability whilst achieving therapeutic effect.
Our clinical team considers your complete medical history, including any diabetes, cardiovascular conditions, or previous weight management attempts when developing your personalised conversion plan. The decision between continuing Wegovy optimisation versus transitioning to Mounjaro involves evaluating your current progress against NICE TA875 recommendations for specialist weight management support. Both treatments remain available through EverydayMeds, ensuring continuity of care regardless of which option best suits your evolving needs throughout your prescription weight loss journey.
Complete Your Wegovy to Mounjaro Conversion Assessment Today
Take the next step in your prescription weight loss journey by completing our clinical assessment to explore your Wegovy to Mounjaro conversion options. New customers can access either treatment from £79.99 using discount code FIRST40, whilst returning customers benefit from code DOSE25 at checkout. Our experienced prescribers provide personalised guidance based on your individual circumstances, current treatment response, and weight management goals. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and discover which prescription-only medicine may be most suitable for your needs. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which treatment option aligns best with your health objectives and lifestyle requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
